BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33892497)

  • 21. Racial parity in tumor burden, treatment choice and survival outcomes in men with prostate cancer in the VA healthcare system.
    Daskivich TJ; Kwan L; Dash A; Litwin MS
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):104-9. PubMed ID: 25582624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in quality of care among older men with localized prostate cancer.
    Jayadevappa R; Chhatre S; Johnson JC; Malkowicz SB
    Cancer; 2011 Jun; 117(11):2520-9. PubMed ID: 24048800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of race and health care system with disease stage and survival in veterans with larynx cancer.
    Voora RS; Kotha NV; Kumar A; Qiao EM; Qian AS; Panuganti BA; Banegas MP; Weissbrod PA; Stewart TF; Rose BS; Orosco RK
    Cancer; 2021 Aug; 127(15):2705-2713. PubMed ID: 33799314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
    Sarabu N; Dong W; Koroukian SM
    Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.
    Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Saad F; Chun FK; Shariat SF; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Int J Urol; 2018 Nov; 25(11):929-936. PubMed ID: 30146729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
    Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
    Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis.
    Vince RA; Jiang R; Bank M; Quarles J; Patel M; Sun Y; Hartman H; Zaorsky NG; Jia A; Shoag J; Dess RT; Mahal BA; Stensland K; Eyrich NW; Seymore M; Takele R; Morgan TM; Schipper M; Spratt DE
    JAMA Netw Open; 2023 Jan; 6(1):e2250416. PubMed ID: 36630135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men.
    Lopez DS; Polychronopoulou E; Tsilidis KK; Khera M; Su LJ; Fowke JH; Peek MK; Kuo YF; Markides K; Canfield S
    Cancer Prev Res (Phila); 2021 Jul; 14(7):719-728. PubMed ID: 33879532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer.
    Qiao EM; Lynch JA; Lee KM; Kotha NV; Nalawade V; Voora RS; Qian AS; Nelson TJ; Yamoah K; Garraway IP; Stewart TF; Parsons JK; Rose BS
    J Natl Cancer Inst; 2022 Apr; 114(4):592-599. PubMed ID: 34893859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial differences in prostate cancer risk remain among US servicemen with equal access to care.
    Wells TS; Bukowinski AT; Smith TC; Smith B; Dennis LK; Chu LK; Gray GC; Ryan MA
    Prostate; 2010 May; 70(7):727-34. PubMed ID: 20033887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. African-American men and prostate cancer-specific mortality: a competing risk analysis of a large institutional cohort, 1989-2015.
    Williams VL; Awasthi S; Fink AK; Pow-Sang JM; Park JY; Gerke T; Yamoah K
    Cancer Med; 2018 May; 7(5):2160-2171. PubMed ID: 29601662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups.
    Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Trinh QD; Nguyen PL
    Urology; 2014 Aug; 84(2):386-92. PubMed ID: 24975710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term depression incidence and associated mortality among African American and White prostate cancer survivors.
    Parikh RB; Gallo JJ; Wong YN; Robinson KW; Cashy JP; Narayan V; Jayadevappa R; Chhatre S
    Cancer; 2021 Sep; 127(18):3476-3485. PubMed ID: 34061986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration.
    McKay RR; Sarkar RR; Kumar A; Einck JP; Garraway IP; Lynch JA; Mundt AJ; Murphy JD; Stewart TF; Yamoah K; Rose BS
    Cancer; 2021 Feb; 127(3):403-411. PubMed ID: 33036065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
    Nelson TJ; Javier-DesLoges J; Deka R; Courtney PT; Nalawade V; Mell L; Murphy J; Parsons JK; Rose BS
    JAMA Netw Open; 2021 May; 4(5):e219452. PubMed ID: 33999164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
    Powell IJ; Schwartz K; Hussain M
    Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
    Deka R; Courtney PT; Parsons JK; Nelson TJ; Nalawade V; Luterstein E; Cherry DR; Simpson DR; Mundt AJ; Murphy JD; D'Amico AV; Kane CJ; Martinez ME; Rose BS
    JAMA; 2020 Nov; 324(17):1747-1754. PubMed ID: 33141207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racial Disparities in Active Surveillance for Prostate Cancer.
    Krishna S; Fan Y; Jarosek S; Adejoro O; Chamie K; Konety B
    J Urol; 2017 Feb; 197(2):342-349. PubMed ID: 27596691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.
    Ma TM; Romero T; Nickols NG; Rettig MB; Garraway IP; Roach M; Michalski JM; Pisansky TM; Lee WR; Jones CU; Rosenthal SA; Wang C; Hartman H; Nguyen PL; Feng FY; Boutros PC; Saigal C; Chamie K; Jackson WC; Morgan TM; Mehra R; Salami SS; Vince R; Schaeffer EM; Mahal BA; Dess RT; Steinberg ML; Elashoff D; Sandler HM; Spratt DE; Kishan AU
    JAMA Netw Open; 2021 Dec; 4(12):e2139769. PubMed ID: 34964855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort.
    Du XL; Fang S; Coker AL; Sanderson M; Aragaki C; Cormier JN; Xing Y; Gor BJ; Chan W
    Cancer; 2006 Mar; 106(6):1276-85. PubMed ID: 16475208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.